| NCT06921837 | A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer | RECRUITING | PHASE1, PHASE2 | 2025-05-26 | 2029-05 | 2027-05 |
| NCT05954143 | Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer | TERMINATED | PHASE2 | 2023-11-30 | 2024-09-25 | 2024-09-20 |
| NCT06181240 | Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE) | RECRUITING | NA | 2023-11-17 | 2028-03-20 | 2026-02-20 |
| NCT06052852 | Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced Malignancies | ACTIVE_NOT_RECRUITING | PHASE1 | 2023-10-11 | 2028-03 | 2026-03 |
| NCT05662787 | BOLT Lithotripsy RESTORE ATK Trial | COMPLETED | NA | 2023-01-19 | 2024-07-30 | 2024-06-20 |
| NCT05535907 | BOLT Lithotripsy RESTORE BTK Trial | COMPLETED | NA | 2022-09-05 | 2024-04-04 | 2024-04-04 |
| NCT04278144 | A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors | TERMINATED | PHASE1, PHASE2 | 2020-02-24 | 2025-02-14 | 2024-12-10 |